Nycomed adds second lien to woo funds as banks snub senior loan
Norwegian pharmaceutical company Nycomed was forced to introduce a second lien tranche on its Eu5.7bn leveraged loan yesterday (Thursday) after the senior part of the facility failed to attract enough bank investors.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: